The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
I also think this is the article, but no paywall this time.
https://dailyprogress.com/news/nation-world/business/health-care/cancer-treatment-drugs-fda-doses-lung-breast/article_4b5b24b8-21b2-5630-953e-ad837ea32f9c.html
Https://www.youtube.com/watch?v=5htPJ53FhQQ
I think the Washington post mentioned by PYC on X is behind a firewall. This is the video behind it?
A bit like Liberty Mutual insurance moto, "only pay for what you need"
https://www.youtube.com/watch?v=N2i7c0X7tU4
P9, i do not know much about the MM stuff, but as someone who bought 300k+ and paid well over for them (1.59) could it be that the trade "spooked" the MM? Maybe they thought it was going to go on another run, so they hiked both bid and offer. I guess the'll make money what ever the scenario?
Likely to be assisting in NM32 or NM23?
https://numab.com/pipeline/
However, goes out on RNS Reach.
https://www.londonstockexchange.com/news-article/PYC/contract-award/16317341
Someone put on X yesterday https://x.com/Physiomics/status/1750891752691572852?s=20 Although i guess Eli are a big name, this poster is from 2010! Over 13 years ago. 1 of the lead names ( erik ) does not work at PYC anymore. Why would you put something out that is 13+ yrs old?
Is there precedent for a IM for board changes on AIM?
Maybe its a kind of sweep the decks, start a fresh thing?
I know KHJ was tongue in cheek about the directorship of Peter, but is this also common within AIM that a CEO is not (yet) a director? Corn,Kumar,Millen & Chassagnole are.
Not sure if this link will work, but it goes back to 2021, look at the Oncology drugs, no mention of Docetaxel ( even thou Physiomics & Doseme have been partners since 2019 i think ) http://web.archive.org/web/20210614032948/https://doseme-rx.com/why-dosemerx/drug-packages
Yesterday, the RNS said this "During this presentation, Jim Millen CEO and Peter Sargent would be happy to take questions relating to the changes announced yesterday. "
Yet at the bottom it stated Peter was the Chief executive officer.
Looks like they can not get the basics right, or whoever scrutinises these RNS's missed it?
I dont think what Share4 asked re stepping down is so wrong? Its a perfectly valid question? Last week someone on here said that funds from a share sale could be used because of a medical condition? You never know, Jim may have a condition, and wishes to take a back seat? I think any eventuality should be looked at regarding the board move today?